← Back to Search

Educational Support for Cardiac Arrest Family Members (RESURFACE Trial)

N/A
Waitlist Available
Led By Sachin Agarwal, MD, MPH
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
English- or Spanish-speaking
Must not have
Non-English and non-Spanish speaking
Moved to the in-patient floor before initial contact can be established
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months post-discharge.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the effectiveness of an informational website to help family members of cardiac arrest patients reduce stress and provide better care.

Who is the study for?
This trial is for adults over 18 who are close family members of cardiac arrest patients at NewYork Presbyterian Hospital. They must speak English or Spanish and have a device with internet access. Those with medical/psychiatric impairments, no internet/device access, or whose relative passed away are excluded.
What is being tested?
The study tests an informational website designed to help family members of cardiac arrest patients reduce uncertainty and stress after the patient leaves the hospital. It compares the well-being of those using this website against those receiving standard care over three months.
What are the potential side effects?
Since this intervention involves educational information provided through a website, there are no direct physical side effects associated with it. However, participants may experience varying levels of emotional response to the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I speak English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English or Spanish.
Select...
I was moved to a hospital room before first contact was made.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months post-discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mishel Uncertainty in Illness Scale Score - Family Member Form
Secondary study objectives
Cardiac Anxiety Questionnaire Score - fear subscale
Post-Traumatic Stress Disorder Checklist (PCL-5) Score
Zarit Burden Interview 12-item short form score
Other study objectives
ENRICHD Social Support Instrument Score
Intolerance of Uncertainty Scale Score
Systems Usability Scale (SUS) Score
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Informational Intervention ArmExperimental Treatment1 Intervention
Participants in this arm will receive access to the informational intervention program, via a website link that they will access through their own person phone/tablet/computer.
Group II: Control ArmActive Control1 Intervention
Participants in this arm will receive usual care and no access to the informational intervention program.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,486 Previous Clinical Trials
2,655,231 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,783 Previous Clinical Trials
28,184,123 Total Patients Enrolled
Sachin Agarwal, MD, MPHPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
1 Total Patients Enrolled
~46 spots leftby Nov 2025